Discussion about this post

User's avatar
Neural Foundry's avatar

Brilliant roundup on the Clever Hans problem in molecular docking. The finding that Boltz-2's affinity predictions decouple from pose quality is a huge red flag for anyone using these tools in real drug discovery pipelines. I ran into similar issues when a docking model kept suggesting binding in completley destroyed pockets, turns out it was just pattern-matching ligand scaffolds from training data. That $5 per million molecules cost for ArtiDock is pretty wild tho, makes high-throughput feasibl for smaller teams without GPU clusters.

No posts

Ready for more?